TuHURA BIOSCIENCES, INC./NV Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
TuHURA BIOSCIENCES, INC./NV (HURA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $396.54 thousand as of 2016-03-31, per its 10-Q filed 2016-05-12.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2016-05-12
- 2016-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $396.54K.
- 2015-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $515.42K.
- 2015-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $326.67K.
- 2015-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $333.14K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2016-03-31 | $396.54K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $515.42K 10-Q · filed 2016-02-12 |
| 2015-09-30 | $326.67K 10-Q · filed 2015-11-16 |
| 2015-03-31 | $333.14K 10-Q · filed 2016-05-12 |
| 2014-12-31 | $304.50K 10-Q · filed 2016-02-12 |
| 2014-09-30 | $396.37K 10-Q · filed 2015-11-16 |
| 2014-06-30 | $336.85K 10-K · filed 2014-08-28 |
| 2014-03-31 | $734.11K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $341.30K 10-Q · filed 2015-02-12 |
| 2013-09-30 | $340.56K 10-Q · filed 2014-11-07 |
| 2013-06-30 | $1.09M 10-Q · filed 2013-08-12 |
| 2013-03-31 | $764.76K 10-Q · filed 2014-05-15 |
| 2012-12-31 | $172.65K 10-K · filed 2014-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |